Luciana Ansaneli Naves
Overview
Explore the profile of Luciana Ansaneli Naves including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
304
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Rosa I, Soares A, Rodrigues M, Naves L
Clin Diabetes Endocrinol
. 2021 Mar;
7(1):6.
PMID: 33731193
Background: Hypopituitarism in the elderly population is an underdiagnosed condition and may increase comorbidities related to glucose metabolism, dyslipidemia, and cardiovascular risk factors. Optimization of hormone replacement that considers alterations...
12.
Kurizky P, Nobrega O, Soares A, Aires R, de Albuquerque C, Nicola A, et al.
JMIR Res Protoc
. 2021 Mar;
10(3):e24211.
PMID: 33661132
Background: Since the beginning of the COVID-19 pandemic, the world's attention has been focused on better understanding the relation between the human host and the SARS-CoV-2 virus, as its action...
13.
de Castro Dytz O, de Azevedo Berger P, Dytz M, Barbosa B, Jreige Junior A, Reggatieri N, et al.
Endocrine
. 2020 Jun;
69(2):368-376.
PMID: 32524503
Purpose: Acromegaly is considered an important cause of secondary osteoporosis. However, studies on bone mineral density (BMD) have yielded conflicting results and there are few studies that evaluate an accurate...
14.
de Castro L, Dos Santos A, Casulari L, Naves L, Amato A
Diabetes Res Clin Pract
. 2020 Jun;
166:108247.
PMID: 32505717
Aim: To determine the pooled association between variations of prolactin serum levels within the physiological range and the risk of type 2 diabetes mellitus (T2D). Methods: Pubmed, Scopus, Web of...
15.
Porto L, Rosa J, Rosa J, Casulari L, Zimmermann I, Naves L
Endocrine
. 2020 Mar;
68(2):390-398.
PMID: 32124262
Purpose: Epidemiological data on acromegaly therapeutic outcomes in real-life conditions are scarce in Brazil. Information on the geographical accessibility to the dispensation of medicines and its impact on biochemical control...
16.
Boguszewski C, Huayllas M, Vilar L, Naves L, Ribeiro-Oliveira Junior A, Santana Soares B, et al.
Arch Endocrinol Metab
. 2019 Aug;
63(4):328-336.
PMID: 31365632
Objective: Investigate the therapeutic response of acromegaly patients to pegvisomant (PEGV) in a real-life, Brazilian multicenter study. Subjects And Methods: Characteristics of acromegaly patients treated with PEGV were reviewed at...
17.
Carvalho-Furtado A, Carvalho-Louro D, Regattieri N, Rodrigues M, Montenegro M, Ferro A, et al.
Front Endocrinol (Lausanne)
. 2019 Jul;
10:364.
PMID: 31275240
Non-alcoholic fatty liver disease (NAFLD) is common in patients with growth hormone deficiency (GHD). Some noninvasive techniques have been used to quantify liver fat, such as the controlled attenuation parameter...
18.
Kunzler L, Naves L, Casulari L
Front Endocrinol (Lausanne)
. 2019 Jun;
10:380.
PMID: 31244782
The quality of life of acromegalics is compromised. Treatment with the "Think healthy and feel the difference" technique has been described as effective in the improvement of the quality of...
19.
Gonzaga M, de Castro L, Naves L, Mendonca J, Oton de Lima B, Kessler I, et al.
Front Endocrinol (Lausanne)
. 2018 Dec;
9:625.
PMID: 30542321
Prolactinomas are preferentially treated with dopamine agonists. However, a few adenomas are resistant to this treatment. To evaluate the characteristics of patients with resistance to dopamine agonists in the long-term....
20.
Porto L, Zimmermann I, Naves L
Pharmacoecon Open
. 2018 Nov;
3(2):247-254.
PMID: 30390240
Background: Acromegaly is a rare, chronic and debilitating disease whose treatment places a high burden on health systems. In the reality of the Brazilian public health network, many patients are...